Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis

127Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

We studied the state of ultralarge von Willebrand factor (ULVWF) proteolysis in 21 pediatric patients with severe sepsis and found that the overall group of patients had moderately reduced ADAMTS-13 activity, but 31% had severe enzymatic deficiency. The severe deficiency correlated with greater adhesion activity of von Willebrand factor, severity of thrombocytopenia and plasma levels of interleukin-6. It also correlated clinically with severity of illness and organ dysfunction. These results suggest that ULVWF proteolysis is insufficient in septic patients and severely deficient in a subgroup of patients. The deficiency may contribute to the development of thrombocytopenia and ischemic organ failure associated with sepsis. ©2007 Ferrata Storti Foundation.

Cite

CITATION STYLE

APA

Nguyen, T. C., Liu, A., Liu, L., Ball, C., Choi, H., May, W. S., … Dong, J. F. (2007). Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis. Haematologica, 92(1), 121–124. https://doi.org/10.3324/haematol.10262

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free